论文部分内容阅读
自应用积极抗炎、糖皮质激素和细胞毒药物以来,多动脉炎的预后已大为改善。但这些药物可导致各种严重合并症,故病变活动性和对治疗反应的客观测定将是处理的重要依据,特别在没有持续炎症时进行性肾小球瘢痕形成已足可引起肾功能恶化。目前尚无单项的临床或实验室异常是特异性的,血沉(ESR)仍被认为是有价值的非特异性指标。C反应蛋白在急性期相当敏感,其浓度在几小时而不是几天便有明显的改变。本文研究了27例多动脉炎,其中23例为微血管性,4例为结节性多动脉炎,均经病理组织学证
The prognosis for polyarteritis has been greatly improved since active anti-inflammatory, glucocorticoid and cytotoxic drugs have been applied. However, these drugs can lead to a variety of serious complications, so the objective determination of disease activity and response to treatment will be an important basis for treatment, especially in the absence of persistent inflammation of glomerular scarring has been sufficient to cause deterioration of renal function. There are no single clinical or laboratory abnormalities that are specific yet ESR is still considered to be a valuable nonspecific indicator. C-reactive protein in the acute phase is quite sensitive, its concentration in a few hours instead of a few days there are significant changes. In this study, 27 cases of multi-arteritis were studied, of which 23 cases were microvascular and 4 cases were nodular nodosa, all of which were histopathologically